Results 121 to 130 of about 9,802 (262)

Osteonecrose da mandíbula em paciente portador de mieloma múltiplo: patologia secundária ao uso do pamidronato Jaw osteonecrosis in a patient suffering from multiple myeloma: pathology secondary to pamidronate therapy

Revista Brasileira de Hematologia e Hemoterapia, 2005
Descreveremos a ocorrência de osteonecrose da mandíbula associada ao uso de pamidronato (Aredia ) em uma paciente portadora de mieloma múltiplo. Apesar de não ser possível provar definitivamente a associação entre a terapia com bisfosfonatos e a ...
Andréia C. Melo, Marcos Bastos, Maria R. Bastos, Adrieli S. Loureiro, Sérgio S. Araújo   +4 more
doaj   +1 more source

Surgical resection for advanced bisphosphonate-related osteonecrosis of the jaw associated with fibrous dysplasia: a case report [PDF]

, 2020
Yurika Murase, Koji Kishimoto, Shoko Yoshida, Yuki Kunisada, Koichi Kadoya, Soichiro Ibaragi, Akira Sasaki   +6 more
openalex   +1 more source

The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK [PDF]

, 2009
Summary We conducted a case–control study to examine osteonecrosis (ON) incidence, patient characteristics, and selected potential risk factors using two health record databases in the UK.
C. Cooper, M. Steinbuch, R. Stevenson, R. Miday, N. B. Watts, Y Assouline-Dayan, MA Mont, DD Gladman, M Abu-Shakra, CC Mok, J Calvo-Alén, M Etminan, TP Staa van, TP Staa van, TP Staa van, KE Wurst, SL Thomas, JD Lewis, JC Fink, R Rizzoli, SB Woo, SL Ruggiero, RE Marx, G Talamo   +23 more
core   +2 more sources

Systemic Ozone Therapy Improves Oral Hard and Soft Tissue Healing in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Study in Senescent Female Rats

Biomedicines
Background/Objectives: Medication-related osteonecrosis of the jaw (MRONJ) is a challenging condition often associated with bisphosphonate use, leading to impaired bone healing and difficult clinical management.
Leonardo Alan Delanora, Tiburtino José de Lima Neto, Tiago Esgalha da Rocha, Glauco Rodrigues Carmo Silveira, Liran Levin, Jamil Awad Shibli, Edilson Ervolino, Carlos Fernando Mourão, Leonardo P. Faverani   +8 more
doaj   +1 more source

Correction to: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ? [PDF]

, 2023
Takumi Hasegawa, Akiko Kawakita, Naoko Ueda, Ryuichiro Funahara, Atsushi Tachibana, M. Kobayashi, Eisei Kondo, D. Takeda, Yasuyuki Kojima, Sanroku SATO, Souichi Yanamoto, Hideki Komatsubara, Masahiro Umeda, Tadaaki Kirita, H. Kurita, Y. Shibuya, Toshio Komori, Japanese Study Group of Cooperative Dentistry with Medicine (JCDM)   +17 more
openalex   +1 more source

Intravenous bisphosphonate-related osteonecrosis of the jaws: influence of coadjuvant antineoplastic treatment and study of buccodental condition [PDF]

, 2013
Objectives: To determine whether coadjuvant antineoplastic treatment can influence the number and size of bone exposures among patients with intravenous bisphosphonaterelated osteonecrosis of the jaws (iBRONJ), and to analyze the buccodental condition ...
Bagán Sebastián, José Vicente, Margaix Muñoz, María, Poveda Roda, Rafael   +2 more
core   +1 more source

The dynamin inhibitor, dynasore, prevents zoledronate-induced viability loss in human gingival fibroblasts by partially blocking zoledronate uptake and inhibiting endosomal acidification [PDF]

Journal of Applied Oral Science
Objective For treatment of medication-related osteonecrosis of the jaw, one proposed approach is the use of a topical agent to block entry of these medications in oral soft tissues.
Jacob KIRBY, Makayla STANDFEST, Jessica BINKLEY, Charles BARNES, Evan BROWN, Tyler CAIRNCROSS, Alex CARTWRIGHT, Danielle DADISMAN, Colten MOWAT, Daniel WILMOT, Theodore HOUSEMAN, Conner MURPHY, Caleb ENGELSMAN, Josh HALLER, Daniel JONES   +14 more
doaj   +1 more source

Osteopathology induced by bisphosphonates and dental implants: clinical observations [PDF]

, 2018
Objectives: Although there are many reports about risk factors for the development of BP-associated osteonecrosis of the jaws, the role of dental implants as a local risk factor is still discussed, especially in patients with oral BP treatment. Until now,
Grätz, Klaus-Wilhelm, Jacobsen, Christine, Metzler, Philipp, Obwegeser, Joachim, Rössle, Matthias, Zemann, Wolfgang   +5 more
core  

Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: A retrospective multi-hospital-based study of 87 Italian cases [PDF]

, 2013
BACKGROUND: Bisphosphonates (BPs) are currently the chief drugs for the prevention/treatment of osteoporosis; one of their adverse effects is the osteonecrosis of the jaw (BRONJ).
CAMPISI, Giuseppina, Colella, G, DI FEDE, Olga, Favia, G, Fusco, V, Gabriele, M, Gaeta, GM, MATRANGA, Domenica, Peluso, F, Solazzo, L, SPRINI, Delia, Vescovi, P   +11 more
core   +1 more source

Osteonecrosis of the jaw in a patient under treatment of osteoporosis with oral bisphosphonate

Autopsy and Case Reports, 2021
Although uncommon in patients under oral therapy, bisphosphonate-related osteonecrosis of the jaw (BRONJ) can be a very severe issue. Early intervention with surgical resection should be the preferable method of treating any stage of the disease ...
Marília A. Figueiredo, Frederico Buhatem Medeiros, Karem López Ortega   +2 more
doaj